H4B Boston is a boutique-like, healthcare communications agency with a passion for rare disease. Our expertise, core values, and co-creative spirit focus on helping educate and bring new therapies to patients, caregivers, and families to help them fight for more chances to live their best lives possible.
With Novartis Gene Therapies, H4B Boston launched a robust educational platform to demystify and drive the first-ever gene therapy treatment for SMA. Our passion inspired a data-driven launch that transformed the treatment landscape and mobilized support for early detection and treatment impacting families around the world.
Within a remarkably tight schedule, H4B Boston answered with lockstep collaboration with clients, drove co-creation at every level, dug deep for smart, strategic insights, and displayed the grit to face down every obstacle. That’s how you get it done.
With only 900 global cases, FOP is one of the world’s rarest diseases. H4B Boston created the “GO FEET FIRST” multichannel awareness campaign to increase education and awareness of FOP with common signs and symptoms. Little feet can mean so much.
When Pompe is misdiagnosed, as it often is, it leaves patients without the treatment they need. Through education, advocacy partnerships, and advanced analytics, H4B Boston continues to strive with our clients to increase the rate of diagnosis, grow new markets, and give patients more chances to live their lives to the fullest.